Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07471425 | Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor | ||
| NCT01159288 | Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes | ||
| NCT03356535 | Metabolic Signature of Healthy Lifestyle and HCC | ||
| NCT04274868 | Pediatric Hepatic Tumors | ||
| NCT06813573 | Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma | ||
| NCT03246841 | Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. | ||
| NCT01864772 | Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC | ||
| NCT03323424 | Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers | ||
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | ||
| NCT02517892 | A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents | ||
| NCT03402568 | Alcohol Consumption and Circulating Metabolites | ||
| NCT01701479 | Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2) | ||
| NCT06787118 | Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer | ||
| NCT05691608 | MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 | ||
| NCT04276376 | Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors | ||
| NCT05821790 | Role of the Tumor Microenvironment in Aggressive Meningiomas | ||
| NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT02151214 | Efficacy of Parenteral Nutrition in Patients at the Palliative Phase of Cancer. | ||
| NCT01864850 | Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC | ||
| NCT00852228 | Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy | ||
| NCT04746729 | Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy | ||
| NCT02094391 | Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma | ||
| NCT06364631 | CARE1 Pragmatic Clinical Trial | ||
| NCT01289522 | Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | ||
| NCT06902883 | Study on the Effectiveness and Comfort of Innovative Solutions for the Internal Transport of Patients in Wheelchairs in a Hospital Setting | ||
| NCT03604588 | Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers | ||
| NCT00181025 | Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle | ||
| NCT06332274 | tislelizUMaB in canceR Patients With molEcuLar residuaL Disease | ||
| NCT04304924 | Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer | ||
| NCT02813135 | European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors | ||
| NCT01706016 | Local Treatment by Thermic Destruction of Primitive Breast Cancer | ||
| NCT03324958 | VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. | ||
| NCT01486251 | Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer | ||
| NCT03613194 | Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer | ||
| NCT07483983 | Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance | ||
| NCT00126269 | Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary | ||
| NCT06439888 | Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer | ||
| NCT04341207 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | ||
| NCT06508216 | A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer | ||
| NCT04349293 | Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways | ||
| NCT02666612 | Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer | ||
| NCT01626638 | Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL) | ||
| NCT06840782 | First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients. | ||
| NCT04477681 | Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults | ||
| NCT00006112 | Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer | ||
| NCT02105168 | Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment | ||
| NCT04965766 | Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer | ||
| NCT06957132 | Analysis of Risk Factors for Hearing Loss in Survivors of Cancer Occurred During Childhood, Adolescence or Young Adulthood | ||
| NCT05692999 | Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study | ||
| NCT02666625 | Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank |
